Anti-cd97 antibodies and antibody-drug conjugates
AssigneeNew York University
InventorsShohei KOIDE, Christopher Y. PARK, Takamitsu HATTORI, Akiko KOIDE, Dimitris PLACANTONAKIS
Life of this patent
Estimating the term…
Abstract
This application relates to isolated antibodies, or antigen-binding fragments thereof, that bind to at least one isoform of cluster of differentiation 97 (CD97), also known as adhesion G protein-coupled receptor E5 (ADGRE5), antibody-drug conjugates comprising such antibodies or antigen-binding fragments, as well as polynucleotides and vectors that encode for such antibodies or antigen-binding fragments. This application further relates to methods of producing the antibodies or antigen-binding fragments and using the antibodies or antigen-binding fragments for treatment of diseases.
Claims31
An antibody, or antigen-binding fragment thereof, that binds to at least one isoform of cluster of differentiation 97 (CD97).
(canceled)
-6. (canceled)
(canceled)
-16. (canceled)
-30. (canceled)
-34. (canceled)
(canceled)
40-46. (canceled)
-52. (canceled)
(canceled)
-75. (canceled)
Dependencies are inferred from the claim text.